Varian sells 4-T MR system for brain study

Article

Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and

Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and psychiatric disorders.

Very high field (4-tesla) systems such as this one cost from $3 million to $4 million and are used only in research applications. In addition to its imaging capabilities, the Varian system can be used for in vivo nuclear MR spectroscopy, a technique for determining structural and functional relationships of chemical compounds in the brain.

Systems have also been ordered by the University of California, Berkeley; Emory University in Atlanta; and the National Institute for Environmental Studies in Tsukuba, Japan.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.